InSite Vision Completes Patient Enrollment In ISV-303 Phase 1/2 Clinical Study For Post-Surgical Ocular Pain And Swelling
Links shared publicly online about this topic.
- 591total visits
InSite Vision Completes Patient Enrollment In ISV-303 Phase 1/2 Clinical Study For Post-Surgical Ocular Pain And Swelling
InSite Vision Incorporated (OTCBB:INSV), a company developing novel ophthalmic therapeutics, has announced that patient enrollment was recently completed in the company's Phase 1/2 clinical trial
View full resource at medicalnewstoday.com
Tags: Edema, Pain, Vision, Clinical Trial
Most Recently Shared on January 10, 2011 at 4:12 pm By:
InSite Vision Completes Enrollment ISV-303 Phase 1/2 Clinical Study Post-Surgical Ocular Pain & Swelling http://j.mp/f2Jk5Q #Eyes
Also Shared By:
Advertisement
MNT Eye Health
@mnt_eyehealth
InSite Vision Completes Patient Enrollment In ISV-303 Phase 1/2 Clinical Study For Post-Surgical Ocular Pain And Swelling http://mnt.to/3PMj
1 year ago...